Sofinnova Venture Partners VI L P

This profile gathers the share dealings of Sofinnova Venture Partners VI L P across 3 companies, led by Anthera Pharmaceuticals Inc, Orexigen Therapeutics, Inc. and Ocera Therapeutics, Inc. Between 1 May 2007 and 18 March 2014, the trades on record add up to 50 filings.

Market trades split into 3 purchases (€1.8M) and 9 sales (€364k). Netting one side against the other leaves €1.4M of net buying. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 8 share grants.

The median purchase comes to €295k.

The record was last updated on 20 March 2014 with a transaction in Ocera Therapeutics, Inc. The clock since the last published purchase (17 July 2013) now reads 4,862 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.